Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242319 · ClinicalTrials.gov registry record
Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice
A clinical trial, sponsored by Memorial Hospital of Rhode Island.
- Completed
- Registry status
- 5,218
- Enrollment target
NCT01242319: Completed study, sponsored by Memorial Hospital of Rhode Island.
NCT01242319 is a clinical trial that has completed, run by Memorial Hospital of Rhode Island. The registered enrollment target is 5,218 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01242319 has completed, sponsored by Memorial Hospital of Rhode Island.
- COMPLETED
- Registry status
- 5,218 participants
- Enrollment target
Study Summary
This quality improvement trial aims to evaluate whether giving patients information about their coronary heart disease risk via a computer kiosk in the doctors waiting room and providing primary care doctors with a personal digital device with a decision support tool to help with cholesterol management will improve cholesterol management compared to usual care.
Primary Outcome
* of patients screened with lipid profiles * patients at LDL goal * patients at non-HDL goals
Interventions
- BEHAVIORAL HeartAge intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,218 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-08 |
What the finished NCT01242319 record still lists
NCT01242319 is an observational study that tracks outcomes without assigning an intervention. Its 5,218 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which HeartAge intervention is the first listed.
NCT01242319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01242319 about?
NCT01242319 is a clinical study titled "Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice". This quality improvement trial aims to evaluate whether giving patients information about their coronary heart disease risk via a computer kiosk in the doctors waiting room and providing primary care doctors with a personal digital device with a decision support tool to help with cholesterol managem...
What is the current status of trial NCT01242319?
This trial is currently completed. The enrollment target is 5,218 participants. The study started on 2002-09. Estimated completion is 2008-08.
What interventions are being tested in trial NCT01242319?
The interventions under investigation include: HeartAge intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01242319?
This trial is sponsored by Memorial Hospital of Rhode Island, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia